We are excited to announce that Interlinked has been selected for the prestigious 2024 Innovate Nordics Acceleration Program! This incredible opportunity, facilitated by The Swedish-American Chamber of Commerce - New York (SACCNY) and EY, marks a significant milestone for our company as we continue our journey to expand our impact in the global healthcare market.
The US market is a critical area of focus for us, and our ReLink catheter protection device, known in the USA as LinkUS, is gaining traction. Through this program, we are eager to collaborate with like-minded, forward-thinking companies, exchange valuable insights, and foster innovation to drive the next generation of healthcare solutions.
The Innovate Nordics Acceleration Program provides a unique platform to enhance our business strategies and build a strong network of partners who share our vision for advancing patient safety and improving IV therapy globally. We are excited to continue our growth and look forward to making a significant impact in the US market.
Stay tuned for more updates as we embark on this exciting journey!
USA, here we come!
Comments